VHL and cancer: Consistent with their genotype but opposite of their in vivo FDG uptake, cancer cells in the Vhl-KO CD45– fraction were significantly enriched for glycolysis and gluconeogenesis transcriptional signatures relative to WT cells (Supplemental Figure 6A).